Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
German pharmaceutical firm Stada said on Tuesday it was generally evaluating all options for its further ownership, including a possible initial public offering. https://t.co/LuTyh1mmaS https://t.co/LuTyh1mmaS
Stada's private equity owners are pushing back a planned IPO of the German drugmaker until September https://t.co/S9ZULSBu8Q
'Duitse farmagroep Stada, bekend van EG, dicht bij startschot beursgang' https://t.co/y4wsfsdmBx https://t.co/TM8jjSKWmV
German pharmaceutical firm Stada is preparing to launch its initial public offering (IPO) as early as Wednesday, according to sources familiar with the matter. This move is seen as a significant test for Europe's equity markets. However, reports indicate that Stada's private equity owners are considering delaying the IPO until September. The company has stated that it is evaluating all options for its ownership structure, including the possibility of an IPO. In a separate development, KKR and Warburg Pincus have made an offer for Gerresheimer at nearly €90 per share.
